1. Home
  2. OCUL vs SRCE Comparison

OCUL vs SRCE Comparison

Compare OCUL & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • SRCE
  • Stock Information
  • Founded
  • OCUL 2006
  • SRCE 1863
  • Country
  • OCUL United States
  • SRCE United States
  • Employees
  • OCUL N/A
  • SRCE N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • SRCE Major Banks
  • Sector
  • OCUL Health Care
  • SRCE Finance
  • Exchange
  • OCUL Nasdaq
  • SRCE Nasdaq
  • Market Cap
  • OCUL 1.4B
  • SRCE 1.5B
  • IPO Year
  • OCUL 2014
  • SRCE N/A
  • Fundamental
  • Price
  • OCUL $11.03
  • SRCE $64.09
  • Analyst Decision
  • OCUL Strong Buy
  • SRCE Buy
  • Analyst Count
  • OCUL 7
  • SRCE 2
  • Target Price
  • OCUL $17.33
  • SRCE $72.00
  • AVG Volume (30 Days)
  • OCUL 2.4M
  • SRCE 128.4K
  • Earning Date
  • OCUL 08-06-2025
  • SRCE 07-24-2025
  • Dividend Yield
  • OCUL N/A
  • SRCE 2.33%
  • EPS Growth
  • OCUL N/A
  • SRCE 14.42
  • EPS
  • OCUL N/A
  • SRCE 5.69
  • Revenue
  • OCUL $59,647,000.00
  • SRCE $388,840,000.00
  • Revenue This Year
  • OCUL N/A
  • SRCE $14.37
  • Revenue Next Year
  • OCUL $20.05
  • SRCE $2.46
  • P/E Ratio
  • OCUL N/A
  • SRCE $11.45
  • Revenue Growth
  • OCUL N/A
  • SRCE 7.96
  • 52 Week Low
  • OCUL $5.79
  • SRCE $52.14
  • 52 Week High
  • OCUL $11.78
  • SRCE $68.13
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 76.75
  • SRCE 58.89
  • Support Level
  • OCUL $9.36
  • SRCE $64.30
  • Resistance Level
  • OCUL $9.75
  • SRCE $65.54
  • Average True Range (ATR)
  • OCUL 0.54
  • SRCE 1.29
  • MACD
  • OCUL 0.18
  • SRCE 0.25
  • Stochastic Oscillator
  • OCUL 91.46
  • SRCE 70.06

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About SRCE 1st Source Corporation

1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.

Share on Social Networks: